TNFRSF10B antibody (Tumor Necrosis Factor Receptor Superfamily, Member 10b)

Details for Product anti-TNFRSF10B Antibody No. ABIN1383912, Supplier: Log in to see
Antigen
  • TNFRSF10B
  • dr5
  • cd262
  • killer
  • trick2
  • trickb
  • xDR-M1
  • xDR-M2
  • ztnfr9
  • trailr2
  • trick2a
  • trick2b
  • CD262
  • DR5
  • KILLER
  • KILLER/DR5
  • TRAIL-R2
  • TRAILR2
  • TRICK2
  • TRICK2A
  • TRICK2B
  • TRICKB
  • ZTNFR9
  • Ly98
  • MK
  • tumor necrosis factor receptor superfamily, member 10b
  • tumor necrosis factor receptor superfamily member 10b S homeolog
  • tumor necrosis factor receptor superfamily member 10b L homeolog
  • tumor necrosis factor receptor superfamily member 10b
  • TNF receptor superfamily member 10b
  • Tnfrsf10b
  • TNFRSF10B
  • tnfrsf10b.S
  • tnfrsf10b.L
  • tnfrsf10b
Alternatives
anti-Human TNFRSF10B antibody for Flow Cytometry
Reactivity
Human
329
77
27
1
1
1
1
1
Host
Mouse
179
175
10
6
6
2
Clonality (Clone)
Monoclonal ()
Conjugate
This TNFRSF10B antibody is un-conjugated
23
21
17
8
6
5
5
5
5
4
4
4
4
4
4
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
Application
194
170
72
53
45
33
27
26
16
16
13
4
4
4
3
3
2
1
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Clone B-K29
Isotype IgG1
Specificity Recognises the 42-46 kDa protein
Characteristics Recombinant human TRAIL R2/Fc chimera. Carrier and preservative free
Purification Ion exchange chromatography
Sterility 0.22 μm filtered
Alternative Name CD262 (TNFRSF10B Antibody Abstract)
Background Myeloma X63/AG.8653 x Balb/c spleen cells
Molecular Weight 42-46 kDa
Pathways p53 Signaling, Apoptosis, Positive Regulation of Endopeptidase Activity
Application Notes Neutralizes TRAIL induced apoptosis of U937 cells line.
Restrictions For Research Use only
Format Liquid
Concentration 200µg/200µl
Buffer Phosphate-buffered saline.
Preservative Azide free
Storage 4 °C
Storage Comment Declared stable after 7 days at room temperature. Protect from light. Do not freeze.
Expiry Date 1 week
Product cited in: Chen, Chou, Chang, Chen: "Proteasome inhibitors enhance TRAIL-induced apoptosis through the intronic regulation of DR5: involvement of NF-kappa B and reactive oxygen species-mediated p53 activation." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 180, Issue 12, pp. 8030-9, 2008 (PubMed).

Sato, Niessner, Kopecky, Frye, Goronzy, Weyand: "TRAIL-expressing T cells induce apoptosis of vascular smooth muscle cells in the atherosclerotic plaque." in: The Journal of experimental medicine, Vol. 203, Issue 1, pp. 239-50, 2006 (PubMed).

Vermot-Desroches, Sergent, Bonnin, Wijdenes: "Characterization of monoclonal antibodies directed against trail or trail receptors." in: Cellular immunology, Vol. 236, Issue 1-2, pp. 86-91, 2005 (PubMed).

Did you look for something else?